-
-
In countries endemic for malaria, young children often receive empiric antimalarial therapy for febrile illness, resulting in over treatment and expense.
-
With antimicrobial resistance among clinical bacterial isolates becoming a greater problem with each passing year, the need for novel antibacterial agents has become more urgent than ever.
-
The advisory committee on immunization practices (APIC) and the CDC have updated for the use of the 23 valent pneumococcal polysaccharide vaccine (PPSV23) for the prevention of invasive pneumococcal disease in adults.
-
A retrospective review of CDC laboratory records identified five cases of tick-borne encephalitis (TBE) among U.S. travelers between 2000 and 2009.
-
This subset analysis from a larger prospective, multicenter HIV-HCV coinfection treatment trial found that patients receiving highly active antiretroviral therapy (HAART) in combination with pegylated interferon alfa and ribavirin for HCV were at greater risk for lactic acidosis and hyperlactatemia than those receiving HCV treatment alone.
-
A retrospective observational study was conducted on 30 individuals from a possible 49 persons who were treated for schistosomiasis between 2003 and 2008 at Copenhagen University Hospital, Denmark.
-
In March 2009, 89 active-duty u.s. trainees received yellow fever (YF) vaccination as part of standard preparation for potential travel to sub-Saharan Africa and Central and South America.
-
A retrospective cohort study was conducted of infants < 6 months of age hospitalized with urinary tract infections between 1999 and 2004 at 24 children's hospitals in the United States.
-
A recent report described a fatal case of community-acquired C. difficile diarrhea (CDAD) in a patient receiving antibiotics for a questionable diagnosis of chronic Lyme disease.